Clinical Trial Update: A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of apremilast on MRI outcomes in adults with Psoriatic arthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Psoriatic Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2022-12-19